ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Mortality"

  • 2018 American Transplant Congress

    Living Donor Nephrectomy: Is It as Safe as It Can Be? Analysis of Living Donor Deaths in the United States

    D. Keith,1 J. Brown,2 K. Andreoni.3

    1Medicine, Sacred Heart Hospital, Pensacola, FL; 2President, Clinical Integration Solutions, LLC, Health Safety Consultancy Company, New York, NY; 3Surgery, University of Florida, Gainesville, FL.

    The reported rate of death from living donor nephrectomy is 3 in 10,000 donations. Although this risk is low, the important question is how many…
  • 2018 American Transplant Congress

    Improving Prediction of Post-Transplant Death and Graft Loss with Expanded Clinical Data Collection

    R. Sung,1 J. Magee,1 M. Schnitzler,2 N. Dzebisashvili,3 K. Lentine,2 L. Ly,1 D. Axelrod.4

    1University of Michigan, Ann Arbor; 2Saint Louis University, St. Louis; 3XynManagement, Inc, St. Louis.

    US transplant centers are graded for patient and graft survival of their recipients based on comparison to risk-adjusted expectations using elements captured in the national…
  • 2018 American Transplant Congress

    Specialized Transplant Critical Care Model Improves Access to Transplantation and Short-Term Survival Outcomes after Liver Transplantation in the Highest Acuity Patients

    M. Selim,1 M. Zimmerman,1 J. Kim,1 T. Pearson,1 C. Eriksen,1 M. Wong,1 B. Boettcher,2 K. Regner,3 K. Saeian,4 H. Woehlk,2 J. Hong.1

    1Department of Surgery, Division of Transplant Surgery, Medical College of Wisconsin, Milwaukee, WI; 2Department of Anesthesia, Medical College of Wisconsin, Milwaukee, WI; 3Department of Medicine, Division of Nephrology, Medical College of Wisconsin, Milwaukee, WI; 4Department of Medicine, Division of Gastroenterology, Medical College of Wisconsin, Milwaukee, WI.

    Objective: Liver transplantation (LT) is a lifesaving treatment for end stage liver disease (ESLD). High acuity ESLD patients are disadvantaged as they are frequently denied…
  • 2018 American Transplant Congress

    How Safe is Crossing the ABO Blood Group Barrier? A Meta-Analysis to Determine the Additive Risk of ABO-Incompatible Kidney Transplantation

    A. de Weerd, M. Betjes.

    Nephrology and Kidney Transplantation, Erasmus Medical Center, Rotterdam, Netherlands.

    Background ABO blood group-incompatible (ABOi) kidney transplantation is considered a safe procedure, with non-inferior outcomes in large cohort studies. Its contribution to living kidney transplantation…
  • 2018 American Transplant Congress

    The Outcomes of Candidates Underwent Liver Transplantaion with Portopulmonary Hypertension: A Meta-Analysis

    R. Deng, B. Huang, Y. Shi, Y. Ma.

    Organ Transplantation Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.

    Background: Portopulmonary hypertension(PPH) was once regarded as a contraindicaton in liver transplantation(LT).However,growing evidence indicated that PPH patients underwent LT may show similar outcomes compared to…
  • 2018 American Transplant Congress

    Long Term Renal and Patient Risks for Living Kidney Donors

    Y. Kim, M. Yu, Y. Kim, H. Lee.

    Division of Nephrology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.

    Purpose:Recent studies have issued that living kidney donor (LKD) might be exposed to higher risk for end-stage renal disease (ESRD) and death, compared with healthy…
  • 2018 American Transplant Congress

    Disparate Risk Factors for Early and Late Death Impact Survival after Lung Transplant

    C. Lehr, E. Blackstone, K. McCurry, L. Thuita, W. Tsuang, M. Valapour.

    Cleveland Clinic, Cleveland, OH.

    Purpose: After implementation of the lung allocation score, there has been improvement in one- and three-year survival but not in five-year survival after lung transplant…
  • 2018 American Transplant Congress

    Antihypertensive Medication Use after Kidney Transplant: Practice Variation and Clinical Outcomes

    H. Yamout,1,2 R. Ouseph,1 M. Schnitzler,1 H. Xiao,1 V. Dharnidharka,3 A. Naik,4 N. Lam,5 F. Koraishy,1,2 H. Randall,1 D. Brennan,6 D. Segev,6 B. Kasiske,7 G. Hess,8 K. Lentine.1

    1Saint Louis Univ, St. Louis; 2St. Louis VA, St. Louis; 3Washington Univ, St. Louis; 4Univ Michigan, Ann Arbor, Canada; 5Univ Alberta, Edmonton; 6Johns Hopkins, Baltimore; 7Hennepin County, Minneapolis; 8Symphony Health, Conshohocken.

    Hypertension is common among kidney transplant (KTx) recipients, but the impact of antihypertensive medication (AHM) choice on patient and graft outcomes is not well defined.We…
  • 2018 American Transplant Congress

    Implementation of the Lung Allocation Score is Associated with Decreased Mortality in Combined Liver-Lung Allograft Recipients

    K. Freischlag,1 P. Shroder,2 B. Ezekian,2 M. Mulvihill,2 S. Knechtle.2

    1School of Medicine, Duke University, Durham, NC; 2Surgery, Duke University, Durham, NC.

    Objective: The current system for simultaneous liver-lung transplant (LLT) generally matches a recipient with a donor based on his or her lung allocation score (LAS),…
  • 2018 American Transplant Congress

    Estimation of Mortality on the Wait List

    S. Asrani, L. Jennings, J. Trotter, G. Klintmalm.

    Baylor University Medical Center, Dallas, TX.

    Background: Since the introduction of MELD and MELDNa, the waitlist population has changed. Further, serum creatinine is a poor surrogate of renal dysfunction in patients…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 32
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences